Evidence map›Paper›PMID 30567537›Full record

ArticleMalaria journal2018

Subpatent malaria in a low transmission African setting: a cross-sectional study using rapid diagnostic testing (RDT) and loop-mediated isothermal amplification (LAMP) from Zambezi region, Namibia.

Patrick McCreesh, Davis Mumbengegwi, Kathryn Roberts, Munyaradzi Tambo, Jennifer Smith, Brooke Whittemore, Gerard Kelly, Caitlin Moe, Max Murphy, Mukosha Chisenga and 8 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Evaluation ofiScience · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 5 countries.

Patrick McCreeshMalaria Elimination Initiative, Global Health Group, University of California, San Francisco (UCSF), San Francisco, CA, USA.
Davis MumbengegwiMultidisciplinary Research Center, University of Namibia, Windhoek, Namibia.
Kathryn RobertsMalaria Elimination Initiative, Global Health Group, University of California, San Francisco (UCSF), San Francisco, CA, USA.
Munyaradzi TamboMultidisciplinary Research Center, University of Namibia, Windhoek, Namibia.
Jennifer SmithMalaria Elimination Initiative, Global Health Group, University of California, San Francisco (UCSF), San Francisco, CA, USA.
Brooke WhittemoreDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Gerard KellyBurnet Institute for Medical Research and Public Health, Melbourne, Australia.
Caitlin MoeMalaria Elimination Initiative, Global Health Group, University of California, San Francisco (UCSF), San Francisco, CA, USA.
Max MurphyDivision of HIV, Infectious Diseases and Global Medicine, Department of Medicine, UCSF, San Francisco, CA, USA.
Mukosha ChisengaMultidisciplinary Research Center, University of Namibia, Windhoek, Namibia.
Bryan GreenhouseDivision of HIV, Infectious Diseases and Global Medicine, Department of Medicine, UCSF, San Francisco, CA, USA.
Henry NtukuMalaria Elimination Initiative, Global Health Group, University of California, San Francisco (UCSF), San Francisco, CA, USA.
Immo KleinschmidtDepartment of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Hugh SturrockMalaria Elimination Initiative, Global Health Group, University of California, San Francisco (UCSF), San Francisco, CA, USA.
Petrina UusikuNational Vectorborne Disease Control Programme, Namibia Ministry of Health and Social Services, Windhoek, Namibia.
Roland GoslingMalaria Elimination Initiative, Global Health Group, University of California, San Francisco (UCSF), San Francisco, CA, USA.
Adam BennettMalaria Elimination Initiative, Global Health Group, University of California, San Francisco (UCSF), San Francisco, CA, USA.
Michelle S HsiangMalaria Elimination Initiative, Global Health Group, University of California, San Francisco (UCSF), San Francisco, CA, USA. michelle.hsiang@utsouthwestern.edu.
University of California, San Francisco · USUniversity of Namibia · NABurnet Institute · AULondon School of Hygiene & Tropical Medicine · GBMinistry of Health and Social Services · NAThe University of Texas Southwestern Medical Center · USUCSF Benioff Children's Hospital · US

Funding

Evaluating Re-active Surveillance Strategies for Malaria Elimination in SwazilandK23AI101012 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI HSIANG, MICHELLE SANG · 2012 to 2016
$657k
Horchow Family Fund 5300375400Medical Research Council MR/K012126/1NIAID NIH HHS K23 AI101012Novartis Foundation A122666
6 · The paper itself

Abstract

backgroundSubpatent malaria infections, or low-density infections below the detection threshold of microscopy or standard rapid diagnostic testing (RDT), can perpetuate persistent transmission and, therefore, may be a barrier for countries like Namibia that are pursuing malaria elimination. This potential burden in Namibia has not been well characterized.

methodsUsing a two-stage cluster sampling, cross-sectional design, subjects of all age were enrolled during the end of the 2015 malaria transmission season in Zambezi region, located in northeast Namibia. Malaria RDTs were performed with subsequent gold standard testing by loop-mediated isothermal amplification (LAMP) using dried blood spots. Infection prevalence was measured and the diagnostic accuracy of RDT calculated. Relationships between recent fever, demographics, epidemiological factors, and infection were assessed.

resultsPrevalence of Plasmodium falciparum malaria infection was low: 0.8% (16/1919) by RDT and 2.2% (43/1919) by LAMP. All but one LAMP-positive infection was RDT-negative. Using LAMP as gold standard, the sensitivity and specificity of RDT were 2.3% and 99.2%, respectively. Compared to LAMP-negative infections, a higher portion LAMP-positive infections were associated with fever (45.2% vs. 30.4%, p = 0.04), though 55% of infections were not associated with fever. Agricultural occupations and cattle herding were significantly associated with LAMP-detectable infection (Adjusted ORs 5.02, 95% CI 1.77-14.23, and 11.82, 95% CI 1.06-131.81, respectively), while gender, travel, bed net use, and indoor residual spray coverage were not.

conclusionsThis study presents results from the first large-scale malaria cross-sectional survey from Namibia using molecular testing to characterize subpatent infections. Findings suggest that fever history and standard RDTs are not useful to address this burden. Achievement of malaria elimination may require active case detection using more sensitive point-of-care diagnostics or presumptive treatment and targeted to high-risk groups.

Indexed as

AdolescentAdultAgedAged, 80 and overChildChild, PreschoolCross-Sectional StudiesDiagnostic Tests, RoutineFemaleHumansInfantInfant, NewbornMalaria, FalciparumMaleMiddle AgedNamibiaAsymptomaticLAMPMalariaMalaria eliminationNamibiaRapid diagnostic testRDTSubclinicalSubmicroscopicSubpatent

Identifiers

PMID30567537
PMCPMC6299963
OpenAlexW2905588035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.